NEW YORK, Jan. 12, 2021 /PRNewswire/ -- Rowley Law
PLLC is investigating potential securities law violations by Cantel
Medical Corporation (NYSE: CMD) ("Cantel") and its board of
directors concerning the proposed acquisition of the company by
Steris Plc (NYSE: STE) ("Steris"). Under the terms of the
agreement, Cantel common stockholders will receive approximately
$16.93 in cash and 0.33787 of a
Steris ordinary share, or a total of value of approximately
$84.66 per Cantel common share based
on Steris's closing share price of $200.46 on January 11,
2021. The transaction is valued at approximately
$4.6 billion and is expected to close
by June 30, 2021.
If you are a stockholder of Cantel and are interested in
obtaining additional information regarding this investigation,
please visit us
at: http://www.rowleylawpllc.com/investigation/cmd. You may
also contact Shane Rowley, Esq. at
Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at
info@rowleylawpllc.com, or by telephone at 914-400-1920 or
844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class
actions and derivative lawsuits in complex corporate litigation.
For more information about the firm and its attorneys, please visit
http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
View original
content:http://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-cantel-medical-corporation-301206774.html
SOURCE Rowley Law PLLC